MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Association of vestibular disorders with autonomic dysfunction in Parkinson’s Disease

    O. Alenikova, M. Leshkovich (Minsk, Belarus)

    Objective: Investigation of changes in VOR and VCR parameters in PDpatients in relation to motor and autonomic disorders severity. Background: Vestibulo-ocular reflex (VOR) and vestibular-colic…
  • 2023 International Congress

    Familial Parkinson’s: Epidemiological data at Blida University Hospital.

    M. Benmahdjoub, K. Kesraoui, S. Bouchetara, M. Arezki (Blida, Algeria)

    Objective: In Algeria, few epidemiological data published on PD. The objective of this work is to study the epidemiological aspects of familial parkinson (PF) at…
  • 2023 International Congress

    Effectiveness of trampoline training on non-motor outcomes in people with Parkinson’s: preliminary study results

    J. Domingos, J. Gomes, J. Dean, J. Fernandes, J. Vaz, C. Godinho (Monte da Caparica, Portugal)

    Objective: To assess the non-motor benefits of trampoline exercise training in people with PD. Background: Physical exercise is known to positively impact people with Parkinson’s…
  • 2023 International Congress

    Anti-glutamic acid decarboxylase associated encephalitis presenting with new onset movement disorder after COVID-19 infection

    PY. Chen (Taipei, Taiwan)

    Objective: To describe the unusual clinical manifestations in a patient with coronavirus disease 2019 (COVID-19). Background: Movement disorders are uncommon neurological manifestations of severe acute…
  • 2023 International Congress

    Referral patterns from primary care physicians to specialists among people with Parkinson’s disease or a Parkinson’s disease–related disorder

    A. Patel, K. Jinnett, A. Gaur, E. Mearns, B. Cobb, C. Macaluso, J. Weiss, H. Lin, N. Win (South San Francisco, USA)

    Objective: To evaluate referral patterns to a specialist by a primary care provider (PCP) or other healthcare provider (HCP) among people diagnosed with Parkinson’s disease…
  • 2023 International Congress

    Impact of the severity of Parkinson’s disease on skin elasticity

    SY. You, HJ. Park (Daegu, Republic of Korea)

    Objective: To investigate changes in skin elasticity according to the severity of symptoms of Parkinson's disease. Background: Parkinson's disease (PD) is a neurodegenerative disease caused…
  • 2023 International Congress

    Path To Prevention (P2P) Therapeutics Platform Trial in Biomarker Defined Prodromal Parkinson’s Disease: Study Design

    C. Coffey, A. Siderowf, C. Tanner, K. Marek, M. Brumm, T. Simuni, P. Investigators, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio ()

    Objective: To describe the study design and proposed timeline of the first interventional study in  biomarker defined prodromal Parkinson’s Disease (PD). Background: P2P is a…
  • 2023 International Congress

    Potential treatment for CMT2S caused by IGHMBP2 cryptic splice variant, with ASO based therapeutic

    S. Smieszek, C. Tyner, A. Kaden, C. Johnson, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

    Objective: Our objective was to target a specific cryptic splice site variant affecting immunoglobulin mu‐binding protein 2 (IGHMBP2) protein levels with a novel antisense oligonucleotide…
  • 2023 International Congress

    Dance for Parkinson’s disease to improve gait and balance: clinical assessments vs. objective measures.

    HHN. Kalyani, K. Sullivan, G. Moyle, S. Brauer, E. Jeffrey, G. Kerr (Colombo, Sri Lanka)

    Objective: To evaluate how the dance classes based on the Dance for Parkinson’s Disease®(DfPD®) model could improve gait and balance in people with Parkinson’s disease…
  • 2023 International Congress

    Update on the ADOPTION Study: Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)

    Objective: This exploratory trial aims to compare treatment outcomes of adding one daily dose of opicapone (OPC) 50 mg versus an additional dose of levodopa…
  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley